Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a third more sales per ad dollar.
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...